Orphan Drugs Market to Reach $342.4 Billion by 2027, Exhibiting 12.3% CAGR

Strategic Insights -

The global orphan drugs market reached a value of $168.9 Billion in 2021, driven by the increasing prevalence of cancer and other rare genetic disorders, as well as the development of innovative orphan drugs to provide personalized therapy to patients. The market is expected to reach $342.4 Billion by 2027, exhibiting a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period.

Key Takeaways:

  • The global orphan drugs market reached a value of $168.9 Billion in 2021, driven by the increasing prevalence of cancer and other rare genetic disorders.
  • The market is expected to reach $342.4 Billion by 2027, exhibiting a CAGR of 12.3% during the forecast period.
  • Pharmaceutical manufacturers are developing innovative orphan drugs to provide personalized therapy to patients, driving market growth.
  • The market is also being driven by increasing awareness among the masses regarding the benefits of orphan drugs.
  • The emergence of new pharmaceutical drug manufacturers and the implementation of favorable government policies to inhibit the spread of contagious diseases are contributing to market growth.
  • Various product innovations, such as the development of biological orphan drugs, are acting as growth-inducing factors, facilitating their overall demand significantly.
  • Companies mentioned in the report include AbbVie Inc., Alexion Pharmaceuticals Inc., Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG (Roche Holding AG), Jazz Pharmaceuticals Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.

Statistics:

  • Global orphan drugs market value: $168.9 Billion (2021), $342.4 Billion (2027)
  • CAGR: 12.3% (2022-2027)
  • Breakdown by drug type: [insert statistics]
  • Breakdown by disease type: [insert statistics]
  • Breakdown by phase: [insert statistics]
  • Breakdown by top selling drugs: [insert statistics]
  • Breakdown by distribution channel: [insert statistics]
  • Breakdown by region: [insert statistics]

Sources:

  • The "Orphan Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report, ResearchAndMarkets.com
  • [No specific date or publication information provided]
  • ResearchAndMarkets.com
  • press@researchandmarkets.com